FDA Inspection 1159670 — Colep Laupheim Gmbh & Co.
The FDA completed an inspection of Colep Laupheim Gmbh & Co. on December 9, 2020 in Laupheim. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 9, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Laupheim (Germany)
Additional Details
Mutual Recognition Agreement (MRA)